A study published in the Journal of Neuro-Oncology (2000;46:97–103) examined the effects of boswellic acids on tumor growth in female Wistar rats. In this animal model, rats were injected with C6 tumor cells into the right caudate nucleus of the brain. The animals were then divided into four groups: a control group and three treatment groups receiving different doses of boswellic acids.
Boswellic acids are bioactive compounds derived from Boswellia serrata, a tree native to India. The tree produces a gum resin known as salai guggul, which has been used traditionally for centuries to support inflammatory balance in conditions such as arthritis, irritable bowel disorders, Crohn’s disease, and asthma. Boswellic acids are considered the primary active constituents of this resin.
Rats receiving the highest dose of boswellic acids (3 × 240 mg/kg body weight) had the longest survival, living approximately twice as long as the control group. Post-mortem examination also showed that tumors in the high-dose group were substantially smaller than those observed in the low-dose and control groups.
While these findings are limited to an animal model and cannot be directly applied to humans, they suggest that boswellic acids may influence tumor growth and survival under experimental conditions. Further research would be needed to clarify mechanisms and relevance to human health.
